Recent Security Class Actions

Aurinia Pharmaceuticals Inc Ordinary Shares (NASDAQ: AUPH)

Company Name:Aurinia Pharmaceuticals Inc Ordinary Shares
Stock Symbol:NASDAQ: AUPH
Class Period Start:05/07/2021
Class Period End (inclusive):02/25/2022

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) Aurinia was experiencing declining revenues; (ii) Aurinia’s 2022 sales outlook for LUPKYNIS would fall well short of expectations; (iii) accordingly, the Company had significantly overstated LUPKYNIS’s commercial prospects; (iv) as a result, the Company had overstated its financial position and/or prospects for 2022; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.